Abstract:Aims: Perfluorocarbons (PFCs) are inert, oxygen-rich fluids with applications in neonatal and adult liquid ventilation and potential for innovations related to hypoxic environments, such as under water and for space. Despite promising clinical applications, a laboratory model to comprehensively test PFC implications and predict human airway responses is lacking. We hypothesise that an organotypic airway epithelial cell (AEC) model is needed assess PFC impacts and provide predictive outcomes to inform the in vivo scenario that conventional submerged cultures cannot replicate. This study evaluated PFC exposure in two in vitro systems: a traditional submerged model using 16HBE14o- cells and an air-liquid interface (ALI) model using hSABCi and primary nasal AECs, cultured on transwells to mimic the human airway epithelium. Methods: PFC exposures were conducted at 2, 8, and 24 hours (submerged model) and extended to 72 hours (ALI model). We tracked gross morphological changes via microscopy, quantified apoptosis and autophagy markers through protein biochemistry, and assessed epithelial permeability using trans-epithelial electrical resistance (TEER) and tight junction protein abundance. Statistical analyses included at least three biological replicates per condition. Results: In the submerged 16HBE14o- model, PFC exposure led to significant apoptotic changes by 24 hours, with marked autophagic disruption. Nutrient deprivation, confirmed by starvation experiments, was a key driver of cytotoxicity due to media/PFC phase separation. Conversely, hSABCi cells in the ALI model remained viable, with no apoptosis or autophagic disruption over the exposure periods (P > 0.05 vs. control). Similarly, primary nasal AECs showed consistent viability and stability in autophagic and apoptotic markers, indicating a more accurate representation of in vivo conditions. TEER measurements and tight junction protein levels in the ALI model suggested PFC did not compromise epithelial integrity (P > 0.05 vs. control). PBS exposure, included as a liquid control, underscored baseline sensitivity in the primary nAEC model, evidenced by SQSTM1 upregulation and pronounced barrier dysfunction over 24-72 hours (P < 0.05-0.001). These findings underscore the unique biocompatibility of PFC in maintaining cellular integrity, in contrast to the disruptive effects observed with PBS. Conclusion: This is the first study to describe PFC exposure in an organotypic airway model. Results indicate that the ALI model more accurately preserves airway epithelial integrity during PFC exposure than submerged models, which are limited by nutrient depletion effects. The findings support the use of ALI cultures to replicate the human airway architecture for evaluating PFC's biological effects and offer a platform for preclinical applications in respiratory medicine. This organotypic approach may inform future therapeutic and hypoxia-related interventions and contributes significantly to the field by providing a viable model for understanding PFC interactions with airway epithelial cells. We are now trialling PFC emulsions that also contain azithromycin and steroid therapies for extended therapeutic applications.

Development of an in vitro human alveolar epithelial air-liquid interface model using a small molecule inhibitor cocktail

A Bionic Controllable Strain Membrane for Cell Stretching at Air–liquid Interface Inspired by Papercutting

Development of human alveolar epithelial cell models to study distal lung biology and disease

Organoid-based expansion of patient-derived primary alveolar type 2 cells for establishment of alveolus epithelial Lung-Chip cultures

Characterization of Commercially Available Human Primary Alveolar Epithelial Cells

A New Immortalized Human Alveolar Epithelial Cell Model to Study Lung Injury and Toxicity on a Breathing Lung-On-Chip System

Characterization an in vitro 3D alveolar model in COPD

A Microfluidic Lung-on-a-chip Based on Biomimetic Hydrogel Membrane

Investigating the effect of e-cigarettes on alveolar epithelial cells using a novel in vitro aerosol exposure device

High-Throughput Culture Method of Induced Pluripotent Stem Cell-Derived Alveolar Epithelial Cells

Air-liquid interface (ALI) model of human bronchial epithelia cells for the investigation of asthma exacerbations

In vitro model alveoli from photodegradable microsphere templates

Alveolar mimics with periodic strain and its effect on the cell layer formation

Establishment of a human induced pluripotent stem cell derived alveolar organoid for toxicity assessment

Aerosol exposure at air-liquid-interface (AE-ALI) in vitro toxicity system characterisation: Particle deposition and the importance of air control responses

Isolation and Characterization of Alveolar Epithelial Type II Cells Derived from Mouse Embryonic Stem Cells

Epithelial folding of alveolar cells derived from human induced pluripotent stem cells on artificial basement membrane

Transcriptomic Analysis of Air–Liquid Interface Culture in Human Lung Organoids Reveals Regulators of Epithelial Differentiation

Culture impact on the transcriptomic programs of primary and iPSC-derived human alveolar type 2 cells

A miniaturized multicellular platform to mimic the 3D structure of the alveolar-capillary barrier

Organotypic tissue architecture is a requisite for predictive outcomes of perfluorocarbon exposure in airway models